Insider Transactions in Q1 2023 at Vaxcyte, Inc. (PCVX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2023
|
Andrew Guggenhime PRESIDENT AND CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,727
-2.06%
|
$70,807
$41.49 P/Share
|
|
Mar 02
2023
|
Jim Wassil CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,189
-0.7%
|
$48,749
$41.49 P/Share
|
|
Mar 02
2023
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,099
-0.72%
|
$127,059
$41.49 P/Share
|
|
Mar 01
2023
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+21.18%
|
-
|
|
Mar 01
2023
|
Jim Wassil CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+11.68%
|
-
|
|
Mar 01
2023
|
Mikhail Eydelman SVP, GEN COUNSEL & CORP SEC |
BUY
Grant, award, or other acquisition
|
Direct |
13,750
+38.7%
|
-
|
|
Mar 01
2023
|
Elvia Cowan SVP, FINANCE |
BUY
Grant, award, or other acquisition
|
Direct |
7,250
+50.0%
|
-
|
|
Mar 01
2023
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
53,875
+11.17%
|
-
|
|
Jan 10
2023
|
Heath Lukatch Director |
SELL
Open market or private sale
|
Direct |
315
-4.67%
|
$14,490
$46.19 P/Share
|
|
Jan 10
2023
|
Heath Lukatch Director |
BUY
Exercise of conversion of derivative security
|
Direct |
315
+8.39%
|
$5,040
$16.0 P/Share
|